VIKING GLOBAL INVESTORS LP 13D and 13G filings for Viking Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 721,926 0.600% | -4,423,186 (-85.97%) | Filing |
| 2024-02-14 10:13 am Sale | 2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,145,112 5.100% | -713,420 (-12.18%) | Filing |
| 2023-11-02 4:30 pm Purchase | 2023-10-23 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,858,532 5.900% | 5,858,532 (New Position) | Filing |